Vaxxas PTY LTD
Part of The University Of Queensland
- UEI
- Y7KNH2UW56R5
- CAGE
- Z15U0
- SAM.gov registration
- Expired
Company facts
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- Corporate family
-
-
Parent
The University Of Queensland · Saint Lucia, QLD
C13XVQRKLNC6
-
Parent
The University Of Queensland · Saint Lucia, QLD
C13XVQRKLNC6
- SAM.gov registration date
- Website
- vaxxas.com
- Founded
- 2011
- Employees
- 51-250
- Estimated annual revenue
- $10M-$50M
- Industry
-
- Health Care
- Pharmaceuticals, Biotechnology & Life Sciences
- Pharmaceuticals
- SIC code
- 28 Chemical & Allied Products
- Profiles
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Contract obligations by fiscal year
| Fiscal year | Obligated |
|---|---|
| FY2027 To date | $0 |
| FY2026 | $1,072,500 |
| FY2025 | $0 |
| FY2024 | $0 |
| FY2023 | $6,801,291 |
Top agencies by obligations
| Rank | Agency | Obligated, FY2026–FY2027 | Share |
|---|---|---|---|
| 1 | Department of Health and Human Services | $1,072,500 |
Contract awards
Quick answers
Is Vaxxas PTY LTD registered in SAM.gov?
Vaxxas PTY LTD's SAM.gov registration expired on July 7, 2026.
How much has Vaxxas PTY LTD received in federal contracts?
Federal contracts obligated $7,873,791 to Vaxxas PTY LTD in fiscal years 2023 through 2027.
What is Vaxxas PTY LTD's most recent federal award?
Vaxxas PTY LTD's most recent federal contract award is Vaxxas - development of HD-micro array patch (map) to deliver a vaccine against a pandemic strain of influenza, H5N1 (75A50120C00180), from Office of the Assistant Secretary for Preparedness and Response, on September 29, 2020.
On GovTribe
See Vaxxas PTY LTD's full federal record
- Federal contract awards
- Subcontracting relationships
- Funding analysis by agency, NAICS and set-aside
- Similar vendors